Plasmodium falciparum circumsporozoite vaccine immunogenicity and efficacy trial with natural challenge quantitation in an area of endemic human malaria of Kenya

Vaccine

Volumn 14, Issue 8, 1996, Pages 817-827

  Sherwood, J A ^a,b   Copeland, R S ^b,c   Taylor, K A ^a,d   Abok, K ^c   Oloo, A J ^c   Were, J B O ^a   Strickland, G T ^e   Gordon, D M ^f   Ballou, W R ^f   Bales Jr , J D ^j   Wirtz, R A ^f   Wittes, J ^g   Gross, M ^g   Que, J U ^h   Cryz, S J ^h   Oster, C N ⁱ   Roberts, C R ^j   Sadoff, J C ^f  

^a Clinical Research Centre   (Kenya)

^b Saradidi Rural Health Programme   (Kenya)

^c KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^f WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^g GLAXOSMITHKLINE   (United Kingdom)

^h Berna Biotech AG   (Switzerland)

ⁱ WALTER REED ARMY MEDICAL CENTER   (United States)

^j NONE

more..

Author keywords

Entomology; Human malaria; Immunology; Malaria vaccine; Plasmodium falciparum

Indexed keywords

MALARIA VACCINE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG SAFETY; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; KENYA; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SPOROZOITE;

EID: 0030176043     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0264-410X(95)00221-L     Document Type: Article

References (63)

1. 1 Hoffman, S.L., Wistar, R., Ballou, W.R. et al. Immunity to malaria and naturally acquired antibodies to the circumsporozoite protein of Plasmodium falciparum. N. Engl. J. Med. 1986, 315, 601-640
2. 2 Miller, L.H. Research in malaria vaccines (Editorial). N. Engl. J. Med. 1986, 315, 640-641
3. 3 Ballou, W.R., Hoffman, S.L., Sherwood, J.A. et al. Safety and efficacy of a recombinant DNA Plasmodium falciparum sporozoite vaccine. Lancet 1987, i, 1277-1281
4. 4 Herrington, D.A., Clyde, D.F., Losonsky, G. et al. Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoites. Nature (Lond.) 1987, 328, 257-259
5. 5 Hoffman, S.L., Oster, C.N., Plowe, C.V. et al. Naturally acquired antibodies to sporozoites do not prevent malaria: vaccine development implications. Science (Wash., D.C.) 1987, 237, 639-684
6. 6 Nardin, E.H., Herrington, D.A., Davis, J. et al. Conserved repetitive epitope recognized by CD4+ clones from a malaria immunized volunteer. Science (Wash., D.C.) 1989, 246, 1603-1606
7. 7 Hoffman, S.L., Oster, C.N., Mason, C.R. et al. Human lymphocyte proliferative response to a sporozoite T-cell epitope correlates with resistance to falciparum malaria. J. Immunol. 1989, 142, 1299-1303
8. 8 Guiguemdé, T.R., Sturchler, D., Ouédraogo, J.B. et al. Premier essai d'un vaccin antisporozoite contre le paludisme en Afrique avec le (NANP)3-TT (RO40-2361) (First trial of an anti-sporozoite vaccine against malaria in Africa with (NANP)3-TT). Bull. Soc. Française Parasot. 1990, 8Suppl. 1, 642
9. 9 Que, J.U., Cryz, S.J. Jr, Ballou, W.R. et al. Effect of carrier selection on immunogenicity of protein conjugate vaccines against Plasmodium falciparum circumsporozoites. Infect. Immun. 1988, 56, 2645-2649
10. 10 Fries, L.F., Gordon, D.M., Schneider, I. et al. Safety, immunogenicity and efficacy of a Plasmodium falciparum vaccine comprising a circumsporozoite protein repeat region peptide conjugated to Pseudomonas aeruginosa toxin A. Infect. Immun. 1992, 60, 1834-1839
11. 11 Sherwood, J.A., Oster, C.N., Adoyo-Adoyo, M. et al. Safety and immunogenicity of a Plasmodium falciparum sporozoite vaccine: boosting of antibody response in a population with prior natural malaria exposure. Trans. R. Soc. Trop. Med. Hyg. 1991, 85, 336-340
12. 12 Beier, J.C., Onyango, F.K., Ramadan, M. et al. Quantitation of malaria sporozoites in the salivary glands of wild Afrotropical Anopheles. Med. Vet. Entomol. 1991, 5, 63-70
13. 13 Beier, J.C., Onyango, F.K., Koros, J.K. et al. Quantitation of malaria sporozoites transmitted in vitro during salivation by wild Afrotropical Anopheles. Med. Vet. Entomol. 1991, 5, 71-79
14. 14 Beier, J.C., Davis, J.R., Vaughan, J.A., Noden, B.H. and Beier, M.S. Quantitation of Plasmodium falciparum sporozoites transmitted in vitro by experimentally infected Anopheles gambiae and Anopheles stephensi. Am. J. Trop. Med. Hyg. 1991, 44, 564-567
15. 15 Kaseje, D.C.O. and Spencer, H.C. The Saradidi, Kenya, Rural Health Development Programme. Ann. Trop. Med. Parasit. 1987, 81Suppl. 1, 1-12
16. 16 Petrarca, V., Beier, J.C., Onyango, F. et al. Species composition of the Anopheles gambiae complex (Diptera: Culicidae) at two sites in western Kenya. J. Med. Entomol. 1991, 28, 307-313
17. 17 Spencer, H.C., Kaseje, D.C.O., Collins, W.E. et al. The Saradidi, Kenya, Rural Health Development Programme: retrospective demographic analysis. Ann. Trop. Med. Parasit. 1987, 81 Suppl. 1, 24-35
18. 18 Spencer, H.C., Kaseje, D.C.O., Sempebwa, E.K.N., Huong, A.Y., Roberts, J.M. and Mosley, W.H. Community-based malaria control in Saradidi, Kenya: description of the programme and impact on parasitemia rates and antimalarial antibodies. Ann. Trop. Med. Parasit. 1987, 81 Suppl. 1, 13-23
19. 19 Fleiss, J.L. Statistical Methods for Rates and Proportions, 2nd edition. John Wiley and Sons, New York, 1981, pp. 260-280
20. 20 Mitchell, S.W., Mboup, S., Mingle, J. et al. Field evaluation of alternative HIV testing strategy with rapid immunobinding assay and an agglutination assay. Lancet 1991, 337, 1328-1331
21. 21 Dame, J.B., Williams, J.L., McCutchan, T.F. et al. Structure of the gene encoding the immunodominant surface antigen on the sporozoite of the human malaria parasite Plasmodium falciparum. Science (Wash., D.C.) 1984, 225, 593-599
22. 22 Wasserman, G.F., Inacker, R. and Rosenblood, J. Assay, purification and characteristics of a recombinant malaria circumsporozoite fusion protein by high-performance liquid chromatography. J. Chromatogr. 1987, 411, 345-354
23. 23 Snow, R.W., Menon, A. and Greenwood, B.M. Measuring morbidity from malaria. Ann. Trop. Med. Parasit. 1989, 83, 321-323
24. 24 World Health Organization. Bench Aids for the Diagnosis Of Human Malaria. Set No. 2, Plate No. 8, Geneva, 1985
25. 25 Sheridan, M.E. and Clarke, G.S. Improved high-performance liquid chromatographic determination of doxycycline in serum and urine using solid phase extraction of columns. J. Chromatogr. 1988, 434, 253-258
26. 26 Mount, D.L., Nahlen, B.L., Patchen, L.C. and Churchill, F.C. Adaptations of the Saker-Solomons test: simple reliable colorimetric field assays for chloroquine and its metabolites in urine. Bull. WHO 1989, 67, 295-300
27. 27 Saker, E.G. and Solomons, ET. A rapid inexpensive presumptive test for phencyclidine and certain other cross reacting substances. J. Anal. Toxicol. 1979, 3, 220-221
28. 28 Wirtz, R.A., Ballou, W.R., Schneider, I. et al. Plasmodium falciparum: immunogenicity of circumsporozoite protein constructs produced in Escherichia coli. Exp. Parasit. 1987, 63, 166-172
29. 29 Rickman, L.S., Gordon, D.M., Wistar, R. et al. A novel adjuvant containing cell wall skeleton of mycobacteria, monophosphoryl lipid A, and squalene substantially improves the immunogenicity in humans of a malaria circumsporozoite protein vaccine. Lancet 1991, i, 988-1001
30. 30 Hancock, K. and Tsang, V.C.W. Development and optimization of the FAST-ELISA for detecting antibodies to Schistosoma mansoni. J. Immunol. Meth. 1986, 92, 167-179
31. 31 Beier, J.C., Perkins, P.V., Wirtz, R.A., Whitmire, R.E., Mugambi, M. and Hockmeyer, W.T. Field evaluation of an enzyme-linked immunosorbent assay (ELISA) for Plasmodium falciparum sporozoite detection in anopheline mosquitoes from Kenya. Am. J. Trop. Med. Hyg. 1987, 36, 459-468
32. 32 Beier, J.C., Perkins, P.V., Onyango, F.K. et al. Characterization of malaria transmission by Anopheles (Diptera: Culicidae) in western Kenya in preparation for malaria vaccine trials. J. Med. Entomol. 1990, 27, 570-577
33. 33 Taylor, K.A., Koros, J.K., Nduati, J., Copeland, R.S., Collins, F.H. and Brandling-Bennett, A.D. Plasmodium falciparum infection rates in Anopheles gambiae, An. arabiensis, and An. funestus in western Kenya. Am. J. Trop. Med. Hyg. 1990, 43, 124-129
34. 34 Joshi, G.P., Service, M.W. and Pradhan, G.D. A survey of species A and B of the Anopheles gambiae Giles complex in the Kisumu area of Kenya prior to insecticidal spraying with OMS-43 (fenitrothion). Ann. Trop. Med. Parasit. 1975, 69, 91-104
35. 35 Beier, J.C., Perkins, P.V., Koros, J.K. et al. Malaria sporozoite detection by dissection and ELISA to asses infectivity of Afrotropical Anopheles (Diptera: Culicidae). J. Med. Entomol. 1990, 27, 377-384
36. 36 Wirtz, R.A., Zavala, F., Charoenvit, Y. et al. Comparative testing of Plasmodium falciparum sporozoite monoclonal antibodies for ELISA development. Bull. WHO 1987, 65, 39-46
37. 37 Pringle, G.A. Quantitative study of naturally-acquired malaria infections in Anopheles gambiae and Anopheles funestus in a highly malarious area of East Africa. Trans. R. Soc. Trop. Med. Hyg. 1966, 60, 626-632
38. 38 MacDonald, G. The Epidemiology and Control of Malaria. Oxford University Press, London, 1957
39. 39 World Health Organization. Manual on Practical Entomology in Malaria, Part II. Methods and Techniques. W.H.O. Offset Publication 13, 1975
40. 40 Bryan, J.A. and Smalley, M.E. The use of ABO blood groups as markers for mosquito biting studies. Trans. R. Soc. Trop. Med. Hyg. 1978, 72, 357-360
41. 41 Beier, J.C., Perkins, P.V., Wirtz, R.A. et al. Bloodmeal identification by direct enzyme-linked immunosorbent assay (ELISA) tested on Anopheles (Diptera: Culicidae) in Kenya. J. Med. Entomol. 1988, 25, 9-16
42. 42 Allison, A.C. The distribution of the sickle-cell trait in East Africa and elsewhere, and its apparent relationship to the incidence of subtertian malaria. Trans. R. Soc. Trop. Med. Hyg. 1954, 48, 312-318
43. 43 Foy, H. and Kendall, A.G. Haemoglobinopathies. In: Health and Disease in Kenya (Eds Vogel, L.C., Muller, A.S., Odingo, R.S., Onyango, Z. and De Geus, A.). Kenya Literature Bureau, Nairobi, 1982, pp. 437-443
44. 44 Bunn, H.F. Disorders of hemoglobin. In: Harrison's Principles of Internal Medicine, 12th edn. (Ed. Wilson, J.D.). 1991, Chap. 295, pp. 1543-1552
45. 45 Giblett, E.R. Blood groups and blood transfusion. In: Harrison's Principles of Internal Medicine, 12th edn. (Ed. Wilson, J.D.). 1991, Chap. 286, pp. 1495-1500
46. 46 Allison, A.C. Glucose-6-phosphate dehydrogenase deficiency in red blood cells of East Africans. Nature (Lond.) 1960, 186, 531-532
47. 47 Kucers, A. and Bennett, N.M. The Use of Antibiotics, 3rd edn. Heinemann, London, 1979, pp. 606-608
48. 48 Hollingdale, M.R., Appiah, A., Leland, P. et al. Activity of human volunteer sera to candidate Plasmodium falciparum circumsporozoite protein vaccines in the inhibition of sporozoite invasion assay of human hepatoma cells and hepatocytes. Trans. R. Soc. Trop. Med. Hyg. 1990, 84, 325-329
49. 49 Mazier, D., Mellouk, S., Beaudoin, R.L. et al. Effect of antibodies to recombinant and synthetic peptides on P. falciparum sporozoites in vitro. Science (Wash., D.C.) 1986, 231, 156-159
50. 50 Mellouk, S., Mazier, D., Druilhe, P., Berbiguier, N. and Danis, M. In vitro and in vivo results suggesting that anti-sporozoite antibodies do not totally block Plasmodium falciparum sporozoite infectivity. N. Engl. J. Med. 1986, 315, 648
51. 51 Schofield, L. and Nadia, P. Lack of lr gene control in the immune response to malaria. I. A thymus-independent antibody response to the repetitive surface protein of sporozoites. J. Immunol. 1990, 144, 2781-2788
52. 52 Schofield, L. On the function of repetitive domains in protein antigens of Plasmodium and other eukaryotic parasites. Parasit. Today 1991, 7, 99-105
53. 53 Weber, J.L. and Hockmeyer, W.T. Structure of the circumsporozoite protein gene in 18 strains of Plasmodium falciparum. Mol. Biochem. Parasit. 1985, 15, 233-236
54. 54 Sinigaglia, F., Guttinger, M., Kilgus, J. et al. A malarial T-cell epitope recognized in association with mouse and human MHC class II molecules. Nature (Lond.) 1988, 336, 778-780
55. 55 Good, M.F., Pombo, D., Quakyi, I.A. et al. Human T-cell recognition of the circumsporozoite protein of Plasmodium falciparum: immunodominant T-cell domains map to the polymorphic regions of the molecule. Proc. Natl Acad. Sci. USA 1988, 85, 1199-1203
56. 56 Hoffman, S.L., Cannon, L.T., Berzofsky, J.A. et al. Plasmodium falciparum: sporozoite boosting of immunity due to a T-cell epitope on a sporozoite vaccine. Exp. Parasit. 1987, 64, 64-70
57. 57 Link, H.T., Ballou, W.R. and Krzych, U. Immune response to Plasmodium berghei sporozoite antigens. I. Evaluation of murine T cell repertoire following immunization with irradiated sporozoites. Am. J. Trop. Med. Hyg. 1990, 43, 452-463
58. 58 Millet, P., Campbell, G.H., Sulzer, A.J. et al. Immunogenicity of the Plasmodium falciparum asexual blood-stage synthetic peptide vaccine SPf66. Am. J. Trop. Med. Hyg. 1993, 48, 424-431
59. 59 Valero, M.V., Amador, L.R., Galindo, G. et al. Vaccination wiith SPf66, a chemically synthesized vaccine, against Plasmodium falciparum malaria in Colombia. Lancet 1993, 341, 705-710
60. 60 Noya, O., Berti, Y.G., de Noya, B.A. et al. A population-based clinical trial with the SPf66 synthetic Plasmodium falciparum malaria vaccine in Venezuela. J. Infect. Dis. 1994, 170, 396-402
61. 61 Alonso, P.L., Smith, T., Armstrong-Schellenberg, J.R.M. et al. Randomised trial of efficacy of SPf66 vaccine against Plasmodium falciparum malaria in children in southern Tanzania. Lancet 1994, 344, 1175-1181
62. 62 D'Alessandro, U., Leach, A., Drakeley, C.J. et al. Efficacy trial of malaria vaccine SPf66 in Gambian infants. Lancet 1995, 346, 462-467
63. 63 Brown, A.E., Singharaj, P., Webster, H.K. et al. Safety, immunogenicity and limited efficacy study of a recombinant Plasmodium falciparum circumsporozoite vaccine in Thai soldiers. Vaccine 1994, 12, 102-108